Buying Ecstasy Czech

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buying Ecstasy Czech

These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format. All countries. Topics A-Z. The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses. Best practice. We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon. Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it. All publications. More events. More news. We are your source of drug-related expertise in Europe. We prepare and share independent, scientifically validated knowledge, alerts and recommendations. About the EUDA. MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in the context of nightlife and entertainment settings. On this page, you can find the latest analysis of the drug situation for MDMA in Europe, including prevalence of use, seizures, price and purity and more. European Drug Report — home. The drug situation in Europe up to Drug supply, production and precursors. Synthetic stimulants. Heroin and other opioids. New psychoactive substances. Other drugs. Injecting drug use in Europe. Drug-related infectious diseases. Drug-induced deaths. Opioid agonist treatment. Harm reduction. Reported use of the drug appeared to decline temporarily during periods of social distancing during the early phases of the COVID pandemic. The currently available data would, however, suggest an overall relatively stable level of consumption but with national variations in the recent trends observed and the caveat that overall supply side indicators are suggestive of a slight recent decline in availability. About half of the European cities reporting wastewater analysis found an increase in MDMA residues between and , although in most other cities some decline was noted. Overall, available indicators suggest that MDMA production continues within Europe, both for domestic consumption and for export to non-EU markets. The information available is strongly suggestive that most MDMA production continues to be largely concentrated in or around the Netherlands. There are some signs of a reduction in the volume being manufactured in the most recent data. An important caveat here is that this information mostly covers the first years of the pandemic and needs to be interpreted with caution. In addition, while overall the average MDMA content of tablets and purity of powders remained stable in , a recent decrease in the MDMA content of ecstasy tablets was noted in some important source countries, most notably the Netherlands. With a typical MDMA content of to milligrams, the overall strength of tablets available on the retail marketplace still remains high by historical standards. It is difficult to interpret the more recent data with any certainty, but a possible decline in production volumes and some reductions noted in MDMA tablet content may indicate that producers have experienced greater problems sourcing precursor chemicals or that some producers may have switched to producing other substances, either because of market demand or because they are more profitable. It may also reflect a perceived consumer demand for lower-strength products. The use of MDMA is rarely cited as a reason for entering drug treatment in Europe but acute poisonings and deaths are sometimes associated with the consumption of this substance. The use of MDMA therefore continues to represent an important issue for prevention and harm reduction messaging and interventions. The availability of higher strength products potentially increases the risk of adverse health outcomes associated with the consumption of this substance. Interestingly, a decline in MDMA-related presentations by a quarter was observed in sentinel hospital emergency departments with data for and This data set, however, is difficult to interpret in respect to overall trends, as it is not nationally representative, has limited coverage and may reflect either changes in consumption or reporting during the pandemic. While it is again difficult to generalise due to limitations in national and European coverage, the available information from drug checking services suggests that MDMA products are generally less subject to adulteration than other illicit drugs they screened in This does occur however, as illustrated by the inclusion of synthetic cathinones in MDMA tablets observed on some occasions. These sorts of mixtures may also increase the risk to consumers of experiencing unexpected adverse effects and potential harm. This data explorer enables you to view our data on the prevalence of MDMA use by recall period and age range. You can access data by country by clicking on the map or selecting a country from the dropdown menu. Prevalence data presented here are based on general population surveys submitted to the EMCDDA by national focal points. For the latest data and detailed methodological information please see the Statistical Bulletin Prevalence of drug use. Graphics showing the most recent data for a country are based on studies carried out between and Mean daily amounts of MDMA in milligrams per population. Sampling was carried out over a week in March and April Show source tables. Back to list of tables. Homepage Quick links Quick links. GO Results hosted on duckduckgo. Main navigation Data Open related submenu Data. Latest data Prevalence of drug use Drug-induced deaths Infectious diseases Problem drug use Treatment demand Seizures of drugs Price, purity and potency. Drug use and prison Drug law offences Health and social responses Drug checking Hospital emergencies data Syringe residues data Wastewater analysis Data catalogue. Selected topics Alternatives to coercive sanctions Cannabis Cannabis policy Cocaine Darknet markets Drug checking Drug consumption facilities Drug markets Drug-related deaths Drug-related infectious diseases. Recently published Findings from a scoping literature…. Penalties at a glance. Frequently asked questions FAQ : drug…. FAQ: therapeutic use of psychedelic…. Viral hepatitis elimination barometer…. EU Drug Market: New psychoactive…. EU Drug Market: Drivers and facilitators. Statistical Bulletin home. Quick links Search news Subscribe newsletter for recent news Subscribe to news releases. This make take up to a minute. Once the PDF is ready it will appear in this tab. Sorry, the download of the PDF failed. Table of contents Search within the book. Search within the book Operator Any match. Exact term match only. No overall trend emerges from the data on MDMA use. Of the 11 European countries that undertook surveys since and provided confidence intervals, 1 reported higher estimates than their previous comparable survey, 9 reported stable estimates and 1 reported a decrease. Seizures of MDMA precursors increased to 2. The Netherlands, however, reported a lower average MDMA content of ecstasy tablets mg per tablet. MDMA market in Europe. Table 2. Prevalence of drug use in Europe, trends Country Country code Geographical scope Substance Recall period Age Austria AT National Table 3. Masaryk Water Resesrch institute, p. Table 4. Table 5. Table 6. Table 7. Table 8. Table 9. Table Main subject. Target audience. Publication type. European Drug Report main page. On this page. Forensic Toxicology Labs. Prevalence data presented here are based on general populaton surveys submitted to the EMCDDA by national focal points.

Report on Illicit Drugs in the Czech Republic 2023

Buying Ecstasy Czech

This is a summary of the report, which has been published in full in Czech only. Use of Psych. Medicines in Czechia Report on Illicit Drugs in Czechia Our publications Focused bulletin Reports on the situation in the field of addiction. Summary of the Report on Illicit Drugs in the Czech Republic Addiction policy The Czech addiction policy integrates substance and non-substance dependence. It focuses on legal alcohol, tobacco and illegal drugs, psychoactive medicines gambling and digital addictions. The National Strategy for the Prevention and Reduction of Harm Related to Addictive Behaviour is the main strategic policy document in the field of addiction, and the means of meeting its objectives is defined in the action plans. In , the Addiction Policy Action Plan was approved, setting out five main themes: 1 prevention and treatment of addictions, 2 regulated market with addictive substances, 3 effective taxation taking into account the risks posed by products with addictive potential, 4 promotion of the principles of a balanced addiction policy following the priorities of the Czech Presidency of the EU Council, 5 minimisation of the impact of the crisis in Ukraine on the addiction situation in the Czech Republic. The Government's coordinating and advisory body on drug policy issues is the Government Council for Coordination of Addiction Policy Council. At the regional level, addiction policy is implemented through regional drug coordinators and regional strategy documents. At the municipal level, local drug coordinators operate. Legal framework In July , a draft amendment to Act No. The draft introduces new categories of addictive substances, namely so called psychomodulatory substances and new psychoactive substances, and their regulatory system. An intense professional and societal debate continues on the regulation of the non-medical cannabis market. Act No. As of March , nicotine pouches were included among the products subject to availability restrictions under the Act, and as of July , the scope of people who are subjects to the obligation to undergo an orientation examination and a professional medical examination was extended to include people accommodated in asylum facilities. The list of addictive substances included in the Government Regulation No. Funding In , labelled expenditures on addiction policy from state and local government budgets totalled CZK 1, The labelled expenditure of the state administration amounted to CZK 1, Regions provided CZK Compared to the previous year, however, no information was provided on the expenditure of regional police directorates CZK 1, Students' experience with illicit drugs has been declining over the long term, with the exception of cocaine. The average age at first substance use has been rising for a long time. A study of Prague schoolchildren confirms a declining trend in the prevalence of cannabis use among children and adolescents. The gap in cannabis use between boys and girls has long been narrowing. Secondary school students report a long-term prevalence in the use of most illicit drugs that is times higher than that for primary school students. The prevalence of illicit drug use is approximately times higher among men and young people under the age of Prevalence of cannabis use in the general population and among young adults have been stable in the long run, as well as the prevalence of use of ecstasy, methamphetamine and hallucinogenic mushrooms. In case of cocaine, a long-term increase in the prevalence of use may be observed in the last 12 months. When extrapolated to the entire population, this represents thousand people who have used cannabis for self-medication in the last 12 months, approximately thousand of whom have used it exclusively for self-medication. A total of An estimated Health consequences of illicit drug use Infectious diseases and drug overdoses, both non-fatal and fatal, are among the most important harms related to high-risk illicit drug use. Injecting drug use is a major factor in the spread of infectious diseases among drug users. In the Czech Republic, injecting is the primary mode of application of drug use among high-risk opioid or methamphetamine users. The proportion of HIV transmission through injecting drug use in the Czech Republic has long been low, with cases per year 8 in In the case of viral hepatitis C, IDUs account for approximately half of all infections in the long term. Illicit drug users also face other somatic and mental health problems and comorbidities such as psychosis, depressive and anxiety disorders. Approximately people are hospitalised for non-fatal intoxication each year; approximately of these cases are related to illicit drugs. Of the total number of traffic accidents, were caused under the influence of illegal drugs i. In the last ten years, the number of traffic accidents where the culprit was under the influence of illegal drugs has been increasing. In , a total of 64 fatal overdoses caused by illicit drugs, inhalants and psychoactive medicines were detected. There were 53 fatal overdoses caused by illicit drugs and inhalants, most commonly methamphetamine or amphetamine 22 cases and opioids 15 cases. Inhalants were recorded in 11 cases, as well as benzodiazepines. An additional deaths under the influence of illegal drugs and psychoactive medicines are recorded every year. Social correlates and context of illicit drug use People who use drugs often display a combination of negative social and economic factors - they find it difficult to enter the labour market, have poor relationships, financial problems and housing problems. Unstable housing and debts are significant obstacles to recovery and social and economic integration. For high-risk drug users, they can present an intractable problem. People who use drugs often have no stable income and are usually employed as short-term temporary workers, either without a contract or via employment agencies. Many clients of addictology services are registered with the Labour Office and receive social support in the form of financial need benefits. Unstable accommodation or homelessness is reported by three quarters of people who use drugs, with the same proportion reporting debts. The rising cost of living in the context of increasing energy prices and food prices is and increasing trend. Czech households have spent approximately CZK 10 billion on illegal drugs in recent years which corresponds to 0. Addiction prevention Addiction prevention targeting children and young people is part of a broader framework of prevention of risk behaviour coordinated by the Ministry of Education. Only half of the school prevention methodologists have completed accredited studies to perform specialised activities. The system used to certify the proficiency of school-based prevention programmes remains suspended. To date, 80 services providing prevention in addictology have been certified within the prevention system, 52 of which were in universal prevention, 20 in selective prevention and 8 in indicated prevention. Since , the System of Evidence of Prevention Activities has been in place in school prevention, which is optional for schools. Mental health activities have also been implemented in recent years. There is a shortage of selective and indicated prevention programmes. The network of pedagogical-psychological counselling centres 47 in total and educational care centres 33 in total complements the indicated prevention implemented by NGOs. Addictology services The network of addictology services covers the whole spectrum of problems related to substance use and other addictive behaviours and consists of various types of facilities and programmes that are embedded in different disciplines and departmental legal frameworks. According to various data sources, there are approximately programmes implemented by various types of addictology services in the Czech Republic. Of these, there are low-threshold contact centres, 50 outreach programmes, outpatient treatment programmes 10 of them are targeted for children and adolescents , detoxification units, inpatient health care units, therapeutic communities, outpatient aftercare programmes of them are sheltered housing and homes with special regime for substance users; facilities report patients in opioid agonist treatment substitution treatment and an estimated general practitioners providing substitution treatment. Most regions describe the existing network of services as minimal or insufficient. There is an acute shortage of outpatient psychotherapists, and psychiatrists in particular, but also a shortage of other doctors willing to work with people who use drugs. Regions also frequently report a lack of addictology programmes specialising in children and young people. Significant shortcomings are reported by the regions especially in the availability of opioid agonist treatment. The private segment of addictology services is developing. There is a growing range of treatment and counselling interventions provided via the Internet and using new technologies. Participatory and self-help activities have been on the rise in recent years. In , A further 10, people were in mediated contact. In the long term, there is a gradual increase in the number of methamphetamine users. The most common service provided by the low-threshold centres is the needle and syringe exchange programme, and interest in medical services and hygiene services has long been growing. A total of 9. In , 26 low-threshold programmes in a total of 13 cities were involved in the project of naloxone distribution in the form of Nyxoid nasal spray. In , doses were distributed. The facilities reported 42 cases where opioid overdoses were averted through use of the spray. Gelatine capsules for oral use, which are an alternative to injecting, are distributed probably by all the low-threshold programmes; with an estimated , capsules dispensed annually in the Czech Republic. The prevalence of infections among clients of low-threshold programmes remains relatively low. Specific harm reduction programmes at dance and music events are not widespread in the Czech Republic, although they have been more active in recent years. There are about programmes in the recreational setting in the Czech Republic. The low number of these programmes corresponds to the limited financial support for these activities. Outpatient care for PWUDs is provided mainly in psychiatric outpatient clinics, while AT outpatient clinics can be considered specialised. In total, there are approximately outpatient programmes in the Czech Republic. Of the total, The majority are polydrug users 3. Psychiatric outpatient clinics also provide specialized treatment 2, patients. GPs provide substitution products to an estimated 5, patients. Residential care is provided by detoxification and inpatient units of medical treatment facilities, particularly psychiatric hospitals, therapeutic communities, special education facilities, and sheltered housing programmes. In , people were treated in 10 therapeutic communities subsidised by the Office of the Government of the Czech Republic. According to the Register of Social Service Providers , there were a total of 42 aftercare programmes in the Czech Republic in , 23 of them were residential. In , these programmes reported 1. The availability of addictology services in prisons is increasing. In , there were 14 addictologists working in 12 prisons. Drug-free zones are available in all prisons and are used by almost 4 thousand people a year. Treatment in prisons was available in 14 prisons. A total of people took the option of treatment in voluntary treatment units, and people underwent court-ordered protective treatment. Detoxification was carried out in 6 prisons in and 23 people completed the programme. Treatment with opioid agonists substitution treatment was carried out in 6 prisons, with 56 people registered. Methadone is the available substitution. For people going into prison with buprenorphine substitution, treatment may be continued provided that the medication is paid by their own resources. In , treatment was not initiated for any prison inmate. Drug-related crimes In , 4. In the long term, criminal proceedings are most often brought against people who have committed the unauthorized illicit production and other handling of narcotic drugs and psychotropic substances. There were 2, convictions for primary drug law offences, mostly for the unauthorized production, trafficking and sale of methamphetamine and cannabis substances. The main sanction imposed most often was a suspended sentence. The perpetrators were most often found guilty of endangerment under the influence of addictive substance or drunkenness. In , 8. Most of these misdemeanours involved the possession of small quantities of drugs for personal use. Illicit drug markets Methamphetamine is produced and cannabis is grown in the Czech Republic, both on a subsistence and commercial basis. Raw opium from food poppies is extracted and processed on a seasonal basis. Other illegal drugs are imported into the Czech Republic. In addition, pharmaceutical preparations containing NPS of various groups are available on the drug market. Online drug sales, courier distribution and cryptocurrency payments play a significant role. The Police of the Czech Republic and the Customs Administration of the Czech Republic detected a total of indoor cannabis cultivation facilities in In , methamphetamine labs were detected in the Czech Republic, with smaller domestic labs predominating. Bulk production is being moved abroad, especially to Poland, Germany, the Netherlands or Belgium. The main precursors for the production of methamphetamine are pseudoephedrine and ephedrine extracted from pharmaceuticals imported mostly from Poland. The trend of the increasing availability of cocaine and MDMA in the Czech Republic continues; the supply of heroin on the market is decreasing and the Czech Republic remains more of a transit country. In , 3 opioid laboratories were discovered in the Czech Republic, the precursor was the poppy. In criminal proceedings in , 1, seizures of cannabis dry matter The most common were synthetic cathinones 7 substances. Back to top. Map of Aid.

Buying Ecstasy Czech